ACE2 and COVID-19: An early COVID-19 proteomics study of formalin-fixed paraffin-embedded lung tissue from the original Wuhan patients reported higher expression of ACE2, cathepsins B and L and a panel of S100 proteins [39] in SARS-CoV-2 affected lungs.